JPH10506635A - ３−置換−２−オキシンドールの光分解阻止 - Google Patents

３−置換−２−オキシンドールの光分解阻止

Info

Publication number
JPH10506635A
JPH10506635A JP8532298A JP53229896A JPH10506635A JP H10506635 A JPH10506635 A JP H10506635A JP 8532298 A JP8532298 A JP 8532298A JP 53229896 A JP53229896 A JP 53229896A JP H10506635 A JPH10506635 A JP H10506635A
Authority
JP
Japan
Prior art keywords
red
dye
yellow
lake
thienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8532298A
Other languages
English (en)
Japanese (ja)
Inventor
ニューリン，ウィラード・シー，ジュニアー
ローリン，シャロン・エム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPH10506635A publication Critical patent/JPH10506635A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP8532298A 1995-04-24 1995-04-24 ３−置換−２−オキシンドールの光分解阻止 Pending JPH10506635A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
JPH10506635A true JPH10506635A (ja) 1998-06-30

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8532298A Pending JPH10506635A (ja) 1995-04-24 1995-04-24 ３−置換−２−オキシンドールの光分解阻止

Country Status (30)

Country Link
EP (1) EP0827399A1 (sv)
JP (1) JPH10506635A (sv)
KR (1) KR100189585B1 (sv)
CN (1) CN1053667C (sv)
AP (1) AP607A (sv)
AR (1) AR002728A1 (sv)
AU (1) AU692378B2 (sv)
BG (1) BG100531A (sv)
BR (1) BR9602024A (sv)
CO (1) CO4700418A1 (sv)
FI (1) FI973988A (sv)
HR (1) HRP960194A2 (sv)
HU (1) HU216544B (sv)
IL (1) IL117969A0 (sv)
IS (1) IS4339A (sv)
MA (1) MA23848A1 (sv)
NO (1) NO961622L (sv)
NZ (1) NZ286432A (sv)
OA (1) OA10286A (sv)
PE (1) PE34397A1 (sv)
RO (1) RO113305B1 (sv)
RU (1) RU2109510C1 (sv)
SG (1) SG64924A1 (sv)
SI (1) SI9600133A (sv)
SK (1) SK51296A3 (sv)
TR (1) TR199600300A2 (sv)
UA (1) UA42739C2 (sv)
WO (1) WO1996033701A1 (sv)
YU (1) YU25096A (sv)
ZA (1) ZA963210B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111526730B (zh) 2017-12-29 2024-02-23 卡夫食品集团品牌有限责任公司 使用天然稳定剂改善的水包油乳液的氧化稳定性

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
FI973988A0 (sv) 1997-10-17
AP9600787A0 (en) 1996-04-30
YU25096A (sh) 1998-08-14
AU5085196A (en) 1996-11-07
BG100531A (en) 1997-06-30
AP607A (en) 1997-08-27
RU2109510C1 (ru) 1998-04-27
CN1139110A (zh) 1997-01-01
EP0827399A1 (en) 1998-03-11
UA42739C2 (uk) 2001-11-15
IS4339A (is) 1996-10-25
TR199600300A2 (tr) 1996-11-21
FI973988A (sv) 1997-10-17
IL117969A0 (en) 1996-08-04
PE34397A1 (es) 1997-09-29
SI9600133A (en) 1996-10-31
CO4700418A1 (es) 1998-12-29
HU9601057D0 (en) 1996-06-28
OA10286A (en) 1997-09-19
AR002728A1 (es) 1998-04-29
CN1053667C (zh) 2000-06-21
HUP9601057A3 (en) 1997-05-28
KR100189585B1 (ko) 1999-06-01
KR960037656A (ko) 1996-11-19
HU216544B (hu) 1999-07-28
NZ286432A (en) 1998-05-27
ZA963210B (en) 1997-10-23
SK51296A3 (en) 1997-04-09
RO113305B1 (ro) 1998-06-30
NO961622D0 (no) 1996-04-23
HRP960194A2 (en) 1998-02-28
NO961622L (no) 1996-10-25
MA23848A1 (fr) 1996-12-31
HUP9601057A2 (en) 1997-04-28
WO1996033701A1 (en) 1996-10-31
BR9602024A (pt) 1998-10-06
AU692378B2 (en) 1998-06-04
SG64924A1 (en) 1999-05-25

Similar Documents

Publication Publication Date Title
CA1303504C (en) Pharmaceutical formulation containing acrivastine
JP5179363B2 (ja) 固形製剤
ES2437072T3 (es) Preparación sólida
BG63329B1 (bg) Лекарствени форми, съдържащи ибупрофен и кодеин
NL193440C (nl) Farmaceutisch preparaat met analgetische werking.
NL194907C (nl) Farmaceutische samenstellingen die furaanderivaten bevatten.
CA1069441A (en) Pharmaceutical composition containing 2,1,3-benzothiazole
JPH0141608B2 (sv)
JPH10506635A (ja) ３−置換−２−オキシンドールの光分解阻止
US4188393A (en) Treating spastic conditions or relaxing muscles
TW577741B (en) Novel pharmaceutical combination for treating pain comprising paracetamol and buspirone
CA2216931A1 (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles
US4333945A (en) Thiazoline and imidazoline derivatives useful as minor tranquilizers
JP2012176920A (ja) 医薬組成物
US3443014A (en) 1,3-benzoxazine - 2:4 - dione and pharmacologically acceptable alkali metal salts thereof as analgesics
NL8004442A (nl) Nieuwe farmaceutische samenstellingen.
SA93130414B1 (ar) HMG-CoA Reductase التركيبات الدوائية الثابتة المشتملة على مركب مثبط لل